An Update on FDAs Critical Path Initiative Statistical Contributions Robert T. ONeill Ph.D. Director, Office of Biostatistics Center for Drug Evaluation.
September 30, 2005 Lan-Yang Ch’ang, Ph.D. Institute of Biomedical Sciences Academia Sinica [email protected] Scientific Impacts to the Biotech.
1 Chapter 4 Basic Study DESIGN. 2 Types of Clinical Trials 1.Drug Development (Phase 0, Phase I, & Phase II) Dose and activity 2.Experimental (Clinical.
Brand Alternatives (Dr Brown-Myrie)
542-01-#1 David L. DeMets, Ph.D. Dept. of Biostatistics & Medical Informatics 600 Highland Avenue Room K6/446 Phone: 263-1706 E-Mail: [email protected].
